Lincoln National Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-668
| Closed | -$643K | – | 893 |
|
|
2024
Q1 | $643K | Sell |
668
-103
| -13% | -$99.1K | 0.01% | 656 |
|
|
2023
Q4 | $677K | Buy |
771
+256
| +50% | +$225K | 0.01% | 572 |
|
|
2023
Q3 | $424K | Buy |
515
+11
| +2% | +$9.05K | 0.01% | 651 |
|
|
2023
Q2 | $362K | Buy |
504
+90
| +22% | +$64.7K | 0.01% | 722 |
|
|
2023
Q1 | $340K | Buy |
414
+38
| +10% | +$31.2K | 0.01% | 727 |
|
|
2022
Q4 | $271K | Buy |
+376
| New | +$271K | 0.01% | 756 |
|
|
2020
Q1 | – | Sell |
-651
| Closed | -$245K | – | 654 |
|
|
2019
Q4 | $245K | Buy |
+651
| New | +$245K | 0.01% | 552 |
|